AVTX — Avalo Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapMomentum Trap

Annual balance sheet for Avalo Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	18.9	54.6	13.2	7.42	135
Net Total Accounts Receivable
Net Total Receivables	4.39	4.8	1.92	0.136	0.611
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	26	61.8	16.4	8.39	139
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	1.61	2.69	2.41	1.97	1.21
Net Goodwill
Net Intangible Assets
Other Long Term Assets
Total Assets	43.8	80.2	33.4	21	151
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	15.2	19.9	22.1	4.62	6.96
Long Term Debt
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	19.2	57.1	44.3	13.7	17.7
Redeemable Preferred Stock
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Total Equity	24.6	23.1	-10.9	7.3	133
Total Liabilities & Shareholders' Equity	43.8	80.2	33.4	21	151
Total Common Shares Outstanding
Total Preferred Shares Outstanding